left nav
logo
The Prostate Prevention Diagnosis Treatment Support Resources
right nav
spacer

Brachytherapy: some considerations

print page
spacer
spacer
Eligibility
Not all patients have a cancer that is suitable for this approach and at this time we are offering this treatment to those who have tumours with a Gleason score of 6 or less, a PSA of less than 10 and a prostate volume of less than 50 cc’s (cubic centimetres). The results in this group have been very promising, with 90% of patients receiving low PSA readings for 10 - 12 years after their treatment. Prostates in size range of 50 - 70 cc can be reduced in size by a short course of hormone therapy, making brachytherapy possible for these men also.

For information about ongoing research in Brachytherapy see Clinical Trials or visit: http://www.brachy4U.ca
Risks and complications
The side effects include mild discomfort and bruising in the perineum (the region between the anus and scrotum). While the seeds are active and are delivering the radiation to the prostate, urination is usually more frequent and can be more urgent. This is especially true in the first 2 months after the procedure when the radiation is most intense. Burning with urination usually subsides within the first few days.

Occasionally, if the prostate swells following the procedure, the passage of urine may be impaired and a catheter must be inserted until things settle down. This may take only a few days or may last several weeks. The rectum is rarely affected (1-2%), but if this happens, tenderness and burning during bowel movements may occur. These effects settle down as the radiation subsides.

 

Treatment

 

spacer
bottom  nav left
home downloads contact us   Brachytherapy: 1 2 3 4 5 next page
LAST REVISED: Tuesday, March 9, 2004 19:29
contact webmaster
bottom nav right